FDA to Reclassify Pharmaceutical Co-Crystals – Regulatory Focus


Regulatory Focus
FDA to Reclassify Pharmaceutical Co-Crystals
Regulatory Focus
As part of an effort to clarify and help advance the development of pharmaceutical co-crystals, the US Food and Drug Administration (FDA) on Tuesday released revised draft guidance providing information on the appropriate classification of co-crystal …

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd